| Year |
Citation |
Score |
| 2012 |
Blakey D, Wilson MC, Molnár Z. Termination and initial branch formation of SNAP-25-deficient thalamocortical fibres in heterochronic organotypic co-cultures. The European Journal of Neuroscience. 35: 1586-94. PMID 22607004 DOI: 10.1111/J.1460-9568.2012.08120.X |
0.473 |
|
| 2010 |
Molnár Z, Wang WZ, Piñon MC, Blakey D, Kondo S, Oeschger F, Hoerder-Suabedissen A. Subplate and the formation of the earliest cerebral cortical circuits New Aspects of Axonal Structure and Function. 19-31. DOI: 10.1007/978-1-4419-1676-1_2 |
0.464 |
|
| 2006 |
Price DJ, Kennedy H, Dehay C, Zhou L, Mercier M, Jossin Y, Goffinet AM, Tissir F, Blakey D, Molnár Z. The development of cortical connections. The European Journal of Neuroscience. 23: 910-20. PMID 16519656 DOI: 10.1111/J.1460-9568.2006.04620.X |
0.488 |
|
| 2006 |
Molnár Z, Blakey D, Bystron I, Carney RSE. Tract-tracing in developing systems and in postmortem human material using carbocyanine dyes Neuroanatomical Tract-Tracing 3: Molecules, Neurons, and Systems. 366-393. DOI: 10.1007/0-387-28942-9_12 |
0.343 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2004 |
Conroy MJ, Jamieson SJ, Blakey D, Kaufmann T, Engel A, Fotiadis D, Merrick M, Bullough PA. Electron and atomic force microscopy of the trimeric ammonium transporter AmtB. Embo Reports. 5: 1153-8. PMID 15568015 DOI: 10.1038/Sj.Embor.7400296 |
0.194 |
|
| 2012 |
Jenkins DW, Ross S, Veldman-Jones M, Foltz IN, Clavette BC, Manchulenko K, Eberlein C, Kendrew J, Petteruti P, Cho S, Damschroder M, Peng L, Baker D, Smith NR, Weir HM, ... Blakey DC, et al. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. Molecular Cancer Therapeutics. 11: 1650-60. PMID 22679110 DOI: 10.1158/1535-7163.MCT-11-1027 |
0.122 |
|
| 2014 |
Michaud NR, Wang Y, McEachern KA, Jordan JJ, Mazzola AM, Hernandez A, Jalla S, Chesebrough JW, Hynes MJ, Belmonte MA, Wang L, Kang JS, Jovanovic J, Laing N, Jenkins DW, ... ... Blakey DC, et al. Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling. Molecular Cancer Therapeutics. 13: 386-98. PMID 24344235 DOI: 10.1158/1535-7163.Mct-13-0420 |
0.099 |
|
| 2007 |
Hayashi M, MacGregor JT, Gatehouse DG, Blakey DH, Dertinger SD, Abramsson-Zetterberg L, Krishna G, Morita T, Russo A, Asano N, Suzuki H, Ohyama W, Gibson D. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. Mutation Research. 627: 10-30. PMID 17157053 DOI: 10.1016/J.Mrgentox.2006.08.010 |
0.086 |
|
| 2013 |
Laing N, McDermott B, Wen S, Yang D, Lawson D, Collins M, Reimer C, Hall PA, Andersén H, Snaith M, Wang X, Bedian V, Cao ZA, Blakey D. Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer. Molecular Pharmacology. 83: 1247-56. PMID 23558446 DOI: 10.1124/mol.112.084079 |
0.084 |
|
| 2000 |
Hayashi M, MacGregor JT, Gatehouse DG, Adler ID, Blakey DH, Dertinger SD, Krishna G, Morita T, Russo A, Sutou S. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environmental and Molecular Mutagenesis. 35: 234-52. PMID 10737958 DOI: 10.1002/(Sici)1098-2280(2000)35:3<234::Aid-Em10>3.0.Co;2-L |
0.083 |
|
| 2002 |
Davis PD, Dougherty GJ, Blakey DC, Galbraith SM, Tozer GM, Holder AL, Naylor MA, Nolan J, Stratford MR, Chaplin DJ, Hill SA. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Research. 62: 7247-53. PMID 12499266 |
0.082 |
|
| 1987 |
Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Knyba RE, Wawrzynczak EJ, Blakey DC. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Research. 47: 5924-31. PMID 3499221 |
0.078 |
|
| 1988 |
Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Blakey DC, Newell DR. Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages. Cancer Research. 48: 6396-403. PMID 3263186 |
0.076 |
|
| 2000 |
Fisher KD, Ulbrich K, Subr V, Ward CM, Mautner V, Blakey D, Seymour LW. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Therapy. 7: 1337-43. PMID 10918506 DOI: 10.1038/Sj.Gt.3301230 |
0.075 |
|
| 1994 |
Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsh-Volders M, Oleson FB, Pacchierotti F, Romagna F, Shimada H. In vivo rodent erythrocyte micronucleus assay. Mutation Research. 312: 293-304. PMID 7514741 DOI: 10.1016/0165-1161(94)90039-6 |
0.073 |
|
| 2010 |
Bornstein GG, Quéva C, Tabrizi M, van Abbema A, Chavez C, Wang P, Foord O, Ahluwalia K, Laing N, Raja S, Wen S, Green LL, Yang X, Webster C, Stewart R, ... Blakey D, et al. Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies. Investigational New Drugs. 28: 561-74. PMID 19626278 DOI: 10.1007/s10637-009-9291-z |
0.072 |
|
| 2004 |
Evelhoch JL, LoRusso PM, He Z, DelProposto Z, Polin L, Corbett TH, Langmuir P, Wheeler C, Stone A, Leadbetter J, Ryan AJ, Blakey DC, Waterton JC. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3650-7. PMID 15173071 DOI: 10.1158/1078-0432.Ccr-03-0417 |
0.071 |
|
| 2015 |
Hong D, Kurzrock R, Kim Y, Woessner R, Younes A, Nemunaitis J, Fowler N, Zhou T, Schmidt J, Jo M, Lee SJ, Yamashita M, Hughes SG, Fayad L, Piha-Paul S, ... ... Blakey DC, et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Science Translational Medicine. 7: 314ra185. PMID 26582900 DOI: 10.1126/Scitranslmed.Aac5272 |
0.067 |
|
| 1985 |
Blakey DH, Duncan AM, Wargovich MJ, Goldberg MT, Bruce WR, Heddle JA. Detection of nuclear anomalies in the colonic epithelium of the mouse. Cancer Research. 45: 242-9. PMID 3965135 |
0.067 |
|
| 1988 |
Narod SA, Douglas GR, Nestmann ER, Blakey DH. Human mutagens: evidence from paternal exposure? Environmental and Molecular Mutagenesis. 11: 401-15. PMID 3281830 |
0.066 |
|
| 2002 |
Blakey D, Leech A, Thomas GH, Coutts G, Findlay K, Merrick M. Purification of the Escherichia coli ammonium transporter AmtB reveals a trimeric stoichiometry. The Biochemical Journal. 364: 527-35. PMID 12023896 DOI: 10.1042/BJ20011761 |
0.066 |
|
| 1986 |
Blakey DC, White IN. Destruction of cytochrome P-450 and formation of green pigments by contraceptive steroids in rat hepatocyte suspensions. Biochemical Pharmacology. 35: 1561-7. PMID 3707617 DOI: 10.1016/0006-2952(86)90125-5 |
0.065 |
|
| 1996 |
Wentworth P, Datta A, Blakey D, Boyle T, Partridge LJ, Blackburn GM. Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing. Proceedings of the National Academy of Sciences of the United States of America. 93: 799-803. PMID 8570638 DOI: 10.1073/Pnas.93.2.799 |
0.065 |
|
| 2005 |
Torous DK, Hall NE, Illi-Love AH, Diehl MS, Cederbrant K, Sandelin K, Pontén I, Bolcsfoldi G, Ferguson LR, Pearson A, Majeska JB, Tarca JP, Hynes GM, Lynch AM, McNamee JP, ... ... Blakey D, et al. Interlaboratory validation of a CD71-based flow cytometric method (Microflow) for the scoring of micronucleated reticulocytes in mouse peripheral blood. Environmental and Molecular Mutagenesis. 45: 44-55. PMID 15605355 DOI: 10.1002/Em.20081 |
0.064 |
|
| 2007 |
Tweats DJ, Blakey D, Heflich RH, Jacobs A, Jacobsen SD, Morita T, Nohmi T, O'Donovan MR, Sasaki YF, Sofuni T, Tice R. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutation Research. 627: 78-91. PMID 17116417 DOI: 10.1016/J.Mrgentox.2006.10.005 |
0.064 |
|
| 2001 |
Hamada S, Sutou S, Morita T, Wakata A, Asanami S, Hosoya S, Ozawa S, Kondo K, Nakajima M, Shimada H, Osawa K, Kondo Y, Asano N, Sato S, Tamura H, ... ... Blakey DH, et al. Evaluation of the rodent micronucleus assay by a 28-day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)-Mammalian Mutagenicity Study Group (MMS). Environmental and Molecular Mutagenesis. 37: 93-110. PMID 11246216 DOI: 10.1002/em.1017 |
0.063 |
|
| 2002 |
Wade MG, Foster WG, Younglai EV, McMahon A, Leingartner K, Yagminas A, Blakey D, Fournier M, Desaulniers D, Hughes CL. Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: systemic, immune, and reproductive effects. Toxicological Sciences : An Official Journal of the Society of Toxicology. 67: 131-43. PMID 11961226 DOI: 10.1093/toxsci/67.1.131 |
0.063 |
|
| 1988 |
Blakey DC, Skilleter DN, Price RJ, Thorpe PE. Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo. Biochimica Et Biophysica Acta. 968: 172-8. PMID 3257705 DOI: 10.1016/0167-4889(88)90005-5 |
0.062 |
|
| 2013 |
Eberlein C, Kendrew J, McDaid K, Alfred A, Kang JS, Jacobs VN, Ross SJ, Rooney C, Smith NR, Rinkenberger J, Cao A, Churchman A, Marshall JF, Weir HM, Bedian V, ... Blakey DC, et al. A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene. 32: 4406-16. PMID 23108397 DOI: 10.1038/onc.2012.460 |
0.062 |
|
| 1987 |
Thorpe PE, Blakey DC, Brown AN, Knowles PP, Knyba RE, Wallace PM, Watson GJ, Wawrzynczak EJ. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. Journal of the National Cancer Institute. 79: 1101-12. PMID 2890786 |
0.061 |
|
| 1989 |
McLean JR, Blakey DH, Douglas GR, Bayley J. The Auger electron dosimetry of indium-111 in mammalian cells in vitro. Radiation Research. 119: 205-18. PMID 2756113 |
0.06 |
|
| 2002 |
Blakey DC, Ashton SE, Westwood FR, Walker M, Ryan AJ. ZD6126: a novel small molecule vascular targeting agent. International Journal of Radiation Oncology, Biology, Physics. 54: 1497-502. PMID 12459377 DOI: 10.1016/S0360-3016(02)03922-6 |
0.06 |
|
| 2002 |
Cowen RL, Williams JC, Emery S, Blakey D, Darling JL, Lowenstein PR, Castro MG. Adenovirus vector-mediated delivery of the prodrug-converting enzyme carboxypeptidase G2 in a secreted or GPI-anchored form: High-level expression of this active conditional cytotoxic enzyme at the plasma membrane. Cancer Gene Therapy. 9: 897-907. PMID 12386828 DOI: 10.1038/Sj.Cgt.7700514 |
0.059 |
|
| 2010 |
Brown JL, Cao ZA, Pinzon-Ortiz M, Kendrew J, Reimer C, Wen S, Zhou JQ, Tabrizi M, Emery S, McDermott B, Pablo L, McCoon P, Bedian V, Blakey DC. A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. Molecular Cancer Therapeutics. 9: 145-56. PMID 20053776 DOI: 10.1158/1535-7163.MCT-09-0554 |
0.058 |
|
| 2006 |
Corvi R, Ahr HJ, Albertini S, Blakey DH, Clerici L, Coecke S, Douglas GR, Gribaldo L, Groten JP, Haase B, Hamernik K, Hartung T, Inoue T, Indans I, Maurici D, et al. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use. Environmental Health Perspectives. 114: 420-9. PMID 16507466 DOI: 10.1289/ehp.8247 |
0.058 |
|
| 1985 |
Blakey DH. Sister chromatid exchange analysis in the colonic and small intestinal epithelium of the mouse. Cancer Letters. 28: 299-305. PMID 4052999 DOI: 10.1016/0304-3835(85)90038-2 |
0.058 |
|
| 2011 |
Kendrew J, Eberlein C, Hedberg B, McDaid K, Smith NR, Weir HM, Wedge SR, Blakey DC, Foltz I, Zhou J, Kang JS, Barry ST. An antibody targeted to VEGFR-2 Ig domains 4-7 inhibits VEGFR-2 activation and VEGFR-2-dependent angiogenesis without affecting ligand binding. Molecular Cancer Therapeutics. 10: 770-83. PMID 21388971 DOI: 10.1158/1535-7163.MCT-10-0876 |
0.058 |
|
| 1990 |
Mavournin KH, Blakey DH, Cimino MC, Salamone MF, Heddle JA. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Research. 239: 29-80. PMID 2195332 DOI: 10.1016/0165-1110(90)90030-F |
0.057 |
|
| 1987 |
Foxwell BM, Blakey DC, Brown AN, Donovan TA, Thorpe PE. The preparation of deglycosylated ricin by recombination of glycosidase-treated A- and B-chains: effects of deglycosylation on toxicity and in vivo distribution. Biochimica Et Biophysica Acta. 923: 59-65. PMID 3099852 DOI: 10.1016/0304-4165(87)90126-7 |
0.056 |
|
| 1994 |
Blakey DH, Maus KL, Bell R, Bayley J, Douglas GR, Nestmann ER. Mutagenic activity of 3 industrial chemicals in a battery of in vitro and in vivo tests. Mutation Research. 320: 273-83. PMID 7508553 DOI: 10.1016/0165-1218(94)90080-9 |
0.054 |
|
| 1994 |
McGowan-Jordan IJ, Speevak MD, Blakey D, Chevrette M. Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4. Cancer Research. 54: 2568-72. PMID 8168081 |
0.054 |
|
| 1993 |
Blakey DH, Bayley JM, Huang KC. Suitability of human chromosome-specific DNA libraries for mutagenicity studies in Macaca fascicularis. Mutagenesis. 8: 189-92. PMID 8332080 DOI: 10.1093/mutage/8.3.189 |
0.053 |
|
| 1986 |
Blakey DC, Thorpe PE. Immunotoxins. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 4: 292-7. PMID 3539112 DOI: 10.1002/bies.950040615 |
0.053 |
|
| 2002 |
Coutts G, Thomas G, Blakey D, Merrick M. Membrane sequestration of the signal transduction protein GlnK by the ammonium transporter AmtB. The Embo Journal. 21: 536-45. PMID 11847102 DOI: 10.1093/emboj/21.4.536 |
0.053 |
|
| 2002 |
Monks NR, Blakey DC, East SJ, Dowell RI, Calvete JA, Curtin NJ, Arris CE, Newell DR. DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767. European Journal of Cancer (Oxford, England : 1990). 38: 1543-52. PMID 12110502 DOI: 10.1016/S0959-8049(02)00111-9 |
0.052 |
|
| 1998 |
Edge M, Forder C, Hennam J, Lee I, Tonge D, Hardern I, Fitton J, Eckersley K, East S, Shufflebotham A, Blakey D, Slater A. Engineered human carboxypeptidase B enzymes that hydrolyse hippuryl-L-glutamic acid: reversed-polarity mutants. Protein Engineering. 11: 1229-34. PMID 9930672 |
0.051 |
|
| 2003 |
White PA, Douglas GR, Gingerich J, Parfett C, Shwed P, Seligy V, Soper L, Berndt L, Bayley J, Wagner S, Pound K, Blakey D. Development and characterization of a stable epithelial cell line from Muta Mouse lung. Environmental and Molecular Mutagenesis. 42: 166-84. PMID 14556224 DOI: 10.1002/em.10185 |
0.051 |
|
| 2002 |
Goto H, Yano S, Zhang H, Matsumori Y, Ogawa H, Blakey DC, Sone S. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. Cancer Research. 62: 3711-5. PMID 12097279 |
0.051 |
|
| 1985 |
Blakey DC, White IN. Unscheduled DNA synthesis caused by norethindrone and related contraceptive steroids in short-term male rat hepatocyte cultures. Carcinogenesis. 6: 1201-5. PMID 4017188 |
0.051 |
|
| 1987 |
Blakey DC, Watson GJ, Knowles PP, Thorpe PE. Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody. Cancer Research. 47: 947-52. PMID 3492271 |
0.05 |
|
| 1932 |
Blakey D. Novels of 1760-1825 Notes and Queries. 163: 44. DOI: 10.1093/nq/CLXIII.jul16.44-d |
0.05 |
|
| 2003 |
Blakey DC. Anti-cancer drug discovery and development summit. Expert Opinion On Investigational Drugs. 12: 1577-82. PMID 12943502 DOI: 10.1517/13543784.12.9.1577 |
0.05 |
|
| 1994 |
Werlen RC, Lankinen M, Rose K, Blakey D, Shuttleworth H, Melton R, Offord RE. Site-specific conjugation of an enzyme and an antibody fragment. Bioconjugate Chemistry. 5: 411-7. PMID 7849070 DOI: 10.1021/Bc00029A006 |
0.049 |
|
| 1992 |
Steven FS, Blakey DC. The role of fibrin fibrils in the dissociation of a cell surface protease-inhibitor complex and evidence for the recapture of the inhibitor protein. Journal of Enzyme Inhibition. 5: 299-315. PMID 1285251 DOI: 10.3109/14756369109069072 |
0.048 |
|
| 2003 |
Thorpe PE, Chaplin DJ, Blakey DC. The first international conference on vascular targeting: meeting overview. Cancer Research. 63: 1144-7. PMID 12615734 |
0.047 |
|
| 2002 |
Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbins A, Gumbrell L, O'Malley D, Tsiompanou E, Shahbakhti H, Webley S, Hochhauser D, ... ... Blakey D, et al. A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer. 87: 600-7. PMID 12237768 DOI: 10.1038/sj.bjc.6600517 |
0.046 |
|
| 1986 |
White IN, Blakey DC, Green ML, Jarman M, Schulten HR. Factors responsible for the formation of different N-alkylated porphyrins in rat liver microsomal systems exposed to norethindrone. The role of 3 alpha-hydroxysteroid dehydrogenase. The Biochemical Journal. 236: 379-87. PMID 3463301 |
0.046 |
|
| 1992 |
Steven FS, Griffin MM, Blakey DC, Talbot IC, Hanski C, Bell J. Further evidence for different isoenzymic forms of a cell surface protease, guanidinobenzoatase, associated with tumours. Anticancer Research. 12: 2159-64. PMID 1295463 |
0.046 |
|
| 2002 |
Blakey DC, Westwood FR, Walker M, Hughes GD, Davis PD, Ashton SE, Ryan AJ. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1974-83. PMID 12060643 |
0.045 |
|
| 2000 |
Prince HM, Rischin D, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Quinn M, Brettell M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, et al. Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study. Bone Marrow Transplantation. 26: 955-61. PMID 11100274 DOI: 10.1038/sj.bmt.1702650 |
0.045 |
|
| 2001 |
Monks NR, Blakey DC, Curtin NJ, East SJ, Heuze A, Newell DR. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue. British Journal of Cancer. 85: 764-71. PMID 11531265 DOI: 10.1054/bjoc.2001.1947 |
0.045 |
|
| 1999 |
Prince HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, et al. Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 10: 479-81. PMID 10370794 DOI: 10.1023/A:1008317205955 |
0.045 |
|
| 1985 |
Duncan AM, Heddle JA, Blakey DH. Mechanism of induction of nuclear anomalies by gamma-radiation in the colonic epithelium of the mouse. Cancer Research. 45: 250-2. PMID 3965137 |
0.045 |
|
| 2006 |
Thornton J, Blakey D, Scanlon E, Merrick M. The ammonia channel protein AmtB from Escherichia coli is a polytopic membrane protein with a cleavable signal peptide. Fems Microbiology Letters. 258: 114-20. PMID 16630265 DOI: 10.1111/j.1574-6968.2006.00202.x |
0.044 |
|
| 1986 |
Blakey DC, Thorpe PE. Effect of chemical deglycosylation on the in vivo fate of ricin A-chain. Cancer Drug Delivery. 3: 189-96. PMID 3490901 |
0.044 |
|
| 1994 |
Tice RR, Hayashi M, MacGregor JT, Anderson D, Blakey DH, Holden HE, Kirsch-Volders M, Oleson FB, Pacchierotti F, Preston RJ. Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test. Mutation Research. 312: 305-12. PMID 7514742 DOI: 10.1016/0165-1161(94)00016-6 |
0.043 |
|
| 1992 |
Blakey DH, Nestmann ER, Bayley JM, Maus KL, Douglas GR. Mutagenic activity of p-toluenesulfonhydrazide. Toxicology and Industrial Health. 8: 369-76. PMID 7570619 |
0.042 |
|
| 2011 |
Tazzyman S, Barry ST, Ashton S, Wood P, Blakey D, Lewis CE, Murdoch C. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. International Journal of Cancer. Journal International Du Cancer. 129: 847-58. PMID 21328342 DOI: 10.1002/ijc.25987 |
0.041 |
|
| 1995 |
Werlen RC, Offord RE, Blakey DC, East SJ, Melton RG, Rose K. In vitro and in vivo comparison of a randomly coupled antibody fragment-enzyme conjugate with a site-specific conjugate. Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity. 1: 251-4. PMID 9575348 |
0.041 |
|
| 1990 |
Blakey DH, Douglas GR. The role of excision repair in the removal of transient benzo[a]pyrene-induced DNA lesions in Chinese hamster ovary cells. Mutation Research. 236: 35-41. PMID 2366796 DOI: 10.1016/0921-8777(90)90030-9 |
0.04 |
|
| 1984 |
Blakey DH, Douglas GR. Transient DNA lesions induced by benzo[a]pyrene in Chinese hamster ovary cells. Mutation Research. 140: 141-5. PMID 6087132 DOI: 10.1016/0165-7992(84)90059-9 |
0.04 |
|
| 1992 |
Steven F, Griffin M, Blakey D. Reversible dissociation of a tumor-cell surface protease-inhibitor complex. International Journal of Oncology. 1: 59-61. PMID 21584510 |
0.04 |
|
| 1994 |
Farman H, Blakey D, Dore JC, Bellissent-Funel MC, Elliott SR. Neutron diffraction studies of network structure in amorphous phosphorus Physica Scripta. 49: 634-636. DOI: 10.1088/0031-8949/49/5/024 |
0.039 |
|
| 1975 |
Blakey D. Editorial: Is the grass greener? Journal of the Mississippi State Medical Association. 16: 153-4. PMID 1127697 |
0.038 |
|
| 2013 |
Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Research. 73: 2412-7. PMID 23423979 DOI: 10.1158/0008-5472.Can-12-4561 |
0.038 |
|
| 1986 |
Fulton RJ, Blakey DC, Knowles PP, Uhr JW, Thorpe PE, Vitetta ES. Purification of ricin A1, A2, and B chains and characterization of their toxicity. The Journal of Biological Chemistry. 261: 5314-9. PMID 3957927 |
0.038 |
|
| 2004 |
Goto H, Yano S, Matsumori Y, Ogawa H, Blakey DC, Sone S. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7671-6. PMID 15570000 DOI: 10.1158/1078-0432.CCR-04-1171 |
0.037 |
|
| 2015 |
Zhuang X, Herbert JM, Lodhia P, Bradford J, Turner AM, Newby PM, Thickett D, Naidu U, Blakey D, Barry S, Cross DA, Bicknell R. Identification of novel vascular targets in lung cancer. British Journal of Cancer. 112: 485-94. PMID 25535734 DOI: 10.1038/bjc.2014.626 |
0.036 |
|
| 1995 |
Blakey DH, Douglas GR, Huang KC, Winter HJ. Cytogenetic mapping of lambda gt10 lacZ sequences in the transgenic mouse strain 40.6 (Muta Mouse). Mutagenesis. 10: 145-8. PMID 7603331 |
0.036 |
|
| 2013 |
Blakey DH, Lafontaine M, Lavigne J, Sokolowski D, Philippe JM, Sapori JM, Biederbick W, Horre R, Marzi WB, Kondo H, Kuroki Y, Namera A, Okumura T, Yamamoto M, Yashiki M, et al. A screening tool to prioritize public health risk associated with accidental or deliberate release of chemicals into the atmosphere. Bmc Public Health. 13: 253. PMID 23517410 DOI: 10.1186/1471-2458-13-253 |
0.036 |
|
| 1983 |
Duncan AM, Ronen A, Blakey DH. Diurnal variation in the response of gamma-ray-induced apoptosis in the mouse intestinal epithelium. Cancer Letters. 21: 163-6. PMID 6360340 DOI: 10.1016/0304-3835(83)90203-3 |
0.035 |
|
| 2011 |
Gao J, Chesebrough JW, Cartlidge SA, Ricketts SA, Incognito L, Veldman-Jones M, Blakey DC, Tabrizi M, Jallal B, Trail PA, Coats S, Bosslet K, Chang YS. Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth. Cancer Research. 71: 1029-40. PMID 21245093 DOI: 10.1158/0008-5472.CAN-10-2274 |
0.035 |
|
| 1962 |
BLAKEY DL. Suggested guides for use of gamma globulin as a prophylaxis with respect to hepatitis. Journal of the Mississippi State Medical Association. 3: 349-50. PMID 13869771 |
0.035 |
|
| 1995 |
Robbins WA, Baulch JE, Moore D, Weier HU, Blakey D, Wyrobek AJ. Three-probe fluorescence in situ hybridization to assess chromosome X, Y, and 8 aneuploidy in sperm of 14 men from two healthy groups: evidence for a paternal age effect on sperm aneuploidy. Reproduction, Fertility, and Development. 7: 799-809. PMID 8711214 DOI: 10.1071/RD9950799 |
0.034 |
|
| 1983 |
Goldberg MT, Blakey DH, Bruce WR. Comparison of the effects of 1,2-dimethylhydrazine and cyclophosphamide on micronucleus incidence in bone marrow and colon. Mutation Research. 109: 91-8. PMID 6835239 DOI: 10.1016/0027-5107(83)90098-2 |
0.034 |
|
| 2007 |
Tweats DJ, Blakey D, Heflich RH, Jacobs A, Jacobsen SD, Morita T, Nohmi T, O'Donovan MR, Sasaki YF, Sofuni T, Tice R. Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests II. Identification of in vivo-only positive compounds in the bone marrow micronucleus test. Mutation Research. 627: 92-105. PMID 17113817 DOI: 10.1016/J.Mrgentox.2006.10.006 |
0.034 |
|
| 1983 |
McLean JR, Blakey DH, Douglas GR, Kaplan JG. The effect of stannous and stannic (tin) chloride on DNA in Chinese hamster ovary cells. Mutation Research. 119: 195-201. PMID 6828057 DOI: 10.1016/0165-7992(83)90129-X |
0.033 |
|
| 2008 |
Sigurdson AJ, Ha M, Hauptmann M, Bhatti P, Sram RJ, Beskid O, Tawn EJ, Whitehouse CA, Lindholm C, Nakano M, Kodama Y, Nakamura N, Vorobtsova I, Oestreicher U, Stephan G, ... ... Blakey D, et al. International study of factors affecting human chromosome translocations. Mutation Research. 652: 112-21. PMID 18337160 DOI: 10.1016/j.mrgentox.2008.01.005 |
0.033 |
|
| 1995 |
Dore JC, Blakey DM. Structural characteristics of hydrogen-bonded networks in water and ice systems Studies in Physical and Theoretical Chemistry. 83: 85-90. DOI: 10.1016/S0167-6881(06)80764-0 |
0.033 |
|
| 1976 |
Blakey DH, Filion WG. Differential Giemsa staining in plants - II. Morphological changes in chromosome structure observed with interference contrast and scanning electron microscopy Chromosoma. 56: 191-197. DOI: 10.1007/BF00293115 |
0.033 |
|
| 1988 |
Douglas GR, Blakey DH, Clayson DB. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper No. 5. Genotoxicity tests as predictors of carcinogens: an analysis. Mutation Research. 196: 83-93. PMID 3292901 DOI: 10.1016/0165-1110(88)90029-2 |
0.033 |
|
| 1960 |
RUSSELL CS, DEWHURST CJ, BLAKEY DH. The pregnanediol excretion in suspected placental insufficiency. The Journal of Obstetrics and Gynaecology of the British Empire. 67: 1-10. PMID 14440289 |
0.032 |
|
| 2000 |
Ainslie J, Hicks R, Drummond R, Blakey D, Bishop M, McKenzie A. Simulated bone metastases: A case study of two patients with breast cancer: Comment [1] (multiple letters) Australasian Radiology. 44: 130. PMID 10761277 |
0.032 |
|
| 1988 |
Blakey DC, Skilleter DN, Price RJ, Watson GJ, Hart LI, Newell DR, Thorpe PE. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Cancer Research. 48: 7072-8. PMID 3263899 |
0.032 |
|
| 2002 |
Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P. CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy. 4: 147-55. PMID 12006210 DOI: 10.1080/146532402317381857 |
0.031 |
|
| 2002 |
Prince HM, Bashford J, Wall D, Rischin D, Parker N, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Francis P, Wolf M, Januszewicz EH, Richardson G, Scarlett J, et al. Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy. 4: 137-45. PMID 12006209 DOI: 10.1080/146532402317381848 |
0.031 |
|
| 1994 |
Blakey DH. Painting of Macaca fascicularis chromosomes using a DNA probe for human chromosome 2. Mutagenesis. 9: 573. PMID 7854151 |
0.031 |
|
| 2000 |
Monks NR, Calvete JA, Curtin NJ, Blakey DC, East SJ, Newell DR. Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT). British Journal of Cancer. 83: 267-9. PMID 10901381 DOI: 10.1054/bjoc.2000.1240 |
0.031 |
|
| 1999 |
Ainslie J, Hicks R, Drummond R, Blakey D, Bishop M, McKenzie A. Simulated bone metastases: a case study of two patients with breast cancer. Australasian Radiology. 43: 365-8. PMID 10901939 DOI: 10.1046/j.1440-1673.1999.433687.x |
0.03 |
|
| 1988 |
Blakey DC, Thorpe PE. Prevention of carbohydrate-mediated clearance of ricin-containing immunotoxins by the liver. Cancer Treatment and Research. 37: 457-73. PMID 2908639 |
0.03 |
|
| 1958 |
BLAKEY DH, DEWHURST CJ, RUSSELL CS. Delivery before full dilatation with special reference to incision of the cervix. The Journal of Obstetrics and Gynaecology of the British Empire. 65: 644-51. PMID 13576246 DOI: 10.1111/j.1471-0528.1958.tb08572.x |
0.03 |
|
| 2004 |
McIntyre DJ, Robinson SP, Howe FA, Griffiths JR, Ryan AJ, Blakey DC, Peers IS, Waterton JC. Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model. Neoplasia (New York, N.Y.). 6: 150-7. PMID 15140404 DOI: 10.1593/neo.03247 |
0.03 |
|
| 1992 |
Blakey DC. Drug targeting with monoclonal antibodies. A review. Acta Oncologica (Stockholm, Sweden). 31: 91-7. PMID 1637417 DOI: 10.3109/02841869209088274 |
0.028 |
|
| 1994 |
Blakey DC, Pinder PE, Wright AF. Comparison of the cellular internalization of antibodies used either as immunotoxins or in ADEPT. Cell Biophysics. 24: 175-83. PMID 7736522 DOI: 10.1007/BF02789228 |
0.028 |
|
| 1974 |
Blakey D. Public health: past, present and future. Journal of the Mississippi State Medical Association. 15: 46-52. PMID 4593020 |
0.027 |
|
| 1996 |
Blakey DC, Burke PJ, Davies DH, Dowell RI, East SJ, Eckersley KP, Fitton JE, McDaid J, Melton RG, Niculescu-Duvaz IA, Pinder PE, Sharma SK, Wright AF, Springer CJ. ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts. Cancer Research. 56: 3287-92. PMID 8764123 |
0.027 |
|
| 2000 |
Dore JC, Blakey DM, Chieux P, Palleau P. Neutron diffraction studies of an argon/amorphous ice co-deposit using isotopic substitution Physical Chemistry Chemical Physics. 2: 1603-1606. DOI: 10.1039/a909319b |
0.026 |
|
| 1995 |
Blakey DC, Davies DH, Dowell RI, East SJ, Burke PJ, Sharma SK, Springer CJ, Mauger AB, Melton RG. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. British Journal of Cancer. 72: 1083-8. PMID 7577451 DOI: 10.1038/bjc.1995.469 |
0.024 |
|
| 1995 |
Tucker JD, Morgan WF, Awa AA, Bauchinger M, Blakey D, Cornforth MN, Littlefield LG, Natarajan AT, Shasserre C. PAINT: a proposed nomenclature for structural aberrations detected by whole chromosome painting. Mutation Research. 347: 21-4. PMID 7596363 DOI: 10.1016/0165-7992(95)90028-4 |
0.024 |
|
| 1976 |
Blakey DH, Filion WG, Horgen PA. Differential Giemsa staining in plants. III. DNA base composition. Experimental Cell Research. 101: 378-82. PMID 964317 DOI: 10.1016/0014-4827(76)90378-5 |
0.024 |
|
| 2002 |
Combes R, Schechtman L, Stokes WS, Blakey D. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for subchronic/chronic toxicity and carcinogenicity testing. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 43: S112-7. PMID 12388863 |
0.024 |
|
| 2008 |
Fens MH, Hill KJ, Issa J, Ashton SE, Westwood FR, Blakey DC, Storm G, Ryan AJ, Schiffelers RM. Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma. British Journal of Cancer. 99: 1256-64. PMID 18797467 DOI: 10.1038/sj.bjc.6604675 |
0.023 |
|
| 1996 |
Dowell RI, Springer CJ, Davies DH, Hadley EM, Burke PJ, Boyle FT, Melton RG, Connors TA, Blakey DC, Mauger AB. New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link. Journal of Medicinal Chemistry. 39: 1100-5. PMID 8676345 DOI: 10.1021/jm950671l |
0.022 |
|
| 1995 |
Tucker JD, Morgan WF, Awa AA, Bauchinger M, Blakey D, Cornforth MN, Littlefield LG, Natarajan AT, Shasserre C. A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenetics and Cell Genetics. 68: 211-21. PMID 7842739 |
0.022 |
|
| 1993 |
Blakey DC, Valcaccia BE, East S, Wright AF, Boyle FT, Springer CJ, Burke PJ, Melton RG, Bagshawe KD. Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug. Cell Biophysics. 22: 1-8. PMID 7889535 DOI: 10.1007/BF03033863 |
0.021 |
|
| 1995 |
Springer CJ, Dowell R, Burke PJ, Hadley E, Davis DH, Blakey DC, Melton RG, Niculescu-Duvaz I. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT). Journal of Medicinal Chemistry. 38: 5051-65. PMID 8544182 DOI: 10.1021/jm00026a013 |
0.021 |
|
| 1976 |
O'Day DH, Gwynne DI, Blakey DH. Microcyst germination in the cellular slime mold, Polysphondylium pallidum. Effects of actinomycin D and cycloheximide on macromolecular synthesis and enzyme accumulation. Experimental Cell Research. 97: 359-65. PMID 942922 DOI: 10.1016/0014-4827(76)90627-3 |
0.021 |
|
| 2003 |
Wheeler C, Stephens T, Byth K, Green T, Wedge S, Blakey D, Hughes A. Novel approaches in oncology at AstraZeneca European Journal of Cancer, Supplement. 1: 3-8. DOI: 10.1016/S1359-6349(03)80014-9 |
0.021 |
|
| 1992 |
Blakey DH, Bayley JM, Douglas GR. Induction of chromosomal aberrations in Chinese hamster ovary cells by triethyllead acetate. Mutation Research. 298: 1-7. PMID 1279411 DOI: 10.1016/0165-1218(92)90022-R |
0.021 |
|
| 1997 |
Guiney MJ, Smith JG, Worotniuk V, Ngan S, Blakey D. Radiotherapy treatment for isolated loco-regional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCallum Cancer Institute experience, 1981-1990. International Journal of Radiation Oncology, Biology, Physics. 38: 1019-25. PMID 9276368 DOI: 10.1016/S0360-3016(97)00315-5 |
0.021 |
|
| 1993 |
Steven FS, Anees M, Talbot IC, Blakey DC, Hasleton PS. The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sections. Anticancer Research. 13: 2003-10. PMID 8297107 |
0.02 |
|
| 1977 |
Blakey D. Cat-scratch diseases. Journal of the Mississippi State Medical Association. 18: 306. PMID 926174 |
0.018 |
|
| 1975 |
Blakey D. Editorials: Scabies: "the itch". Journal of the Mississippi State Medical Association. 16: 115-6. PMID 1127690 |
0.018 |
|
| 2000 |
Prince HM, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Wall D, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, et al. Docetaxel effectively mobilizes peripheral blood CD34+ cells. Bone Marrow Transplantation. 26: 483-7. PMID 11019836 DOI: 10.1038/sj.bmt.1702540 |
0.017 |
|
| 1997 |
Blakey D. Enzyme prodrug therapy of cancer Expert Opinion On Therapeutic Patents. 7: 965-977. DOI: 10.1517/13543776.7.9.965 |
0.017 |
|
| 1995 |
Blakey DC, Burke PJ, Davies DH, Dowell RI, Melton RG, Springer CJ, Wright AF. Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease. Biochemical Society Transactions. 23: 1047-50. PMID 8654679 DOI: 10.1042/bst0231047 |
0.016 |
|
| 2003 |
Müller L, Blakey D, Dearfield KL, Galloway S, Guzzie P, Hayashi M, Kasper P, Kirkland D, MacGregor JT, Parry JM, Schechtman L, Smith A, Tanaka N, Tweats D, Yamasaki H, et al. Strategy for genotoxicity testing and stratification of genotoxicity test results--report on initial activities of the IWGT Expert Group. Mutation Research. 540: 177-81. PMID 14550501 DOI: 10.1016/j.mrgentox.2003.07.007 |
0.016 |
|
| 1978 |
Powell KE, Taylor A, Phillips BJ, Blakey DL, Campbell GD, Kaufman L, Kaplan W. Cutaneous sporotrichosis in forestry workers. Epidemic due to contaminated Sphagnum moss. Jama. 240: 232-5. PMID 566336 DOI: 10.1001/jama.240.3.232 |
0.016 |
|
| 1995 |
Mayhew JF, Brodsky RC, Blakey D, Petersen W. Low-dose caudal morphine for postoperative analgesia in infants and children: a report of 500 cases. Journal of Clinical Anesthesia. 7: 640-2. PMID 8747562 DOI: 10.1016/0952-8180(95)00089-5 |
0.016 |
|
| 1988 |
Blakey DC, Wawrzynczak EJ, Wallace PM, Thorpe PE. Antibody toxin conjugates: a perspective. Progress in Allergy. 45: 50-90. PMID 3064097 |
0.016 |
|
| 1996 |
Guiney MJ, Smith JG, Worotniuk V, Ngan S, Blakey D. Postoperative radiotherapy for Dukes' B and C rectal cancer: Peter MacCallum Cancer Institute experience. Australasian Radiology. 40: 326-30. PMID 8826744 |
0.015 |
|
| 1979 |
Filion WG, Blakey DH. Differential Giemsa staining in plants. VI. Centromeric banding Canadian Journal of Genetics and Cytology. 21: 373-378. |
0.015 |
|
| 2001 |
Delaney G, Blakey D, Drummond R, Kenny L, Centre RO. Breast radiotherapy: an Australasian survey of current treatment techniques. Australasian Radiology. 45: 170-8. PMID 11380359 DOI: 10.1046/j.1440-1673.2001.00898.x |
0.015 |
|
| 2005 |
Drummond R, Power A, Evans A, Luxford K, Blakey D, Delaney G, Rodger A. Changes in practice of breast cancer radiotherapy 1998-2002: an Australasian survey. Australasian Radiology. 49: 44-52. PMID 15727609 DOI: 10.1111/j.1440-1673.2005.01393.x |
0.014 |
|
| 1954 |
BLAKEY D. Our audit program works. The Mississippi Doctor. 32: 14-6. PMID 13165382 |
0.014 |
|
| 2009 |
Blakey D. Breathe easy Engineer. 294: 36-38. |
0.014 |
|
| 1977 |
Powell KE, Andrews RH, Fussel P, Blakey DL. Rabies in Mississippi. Journal of the Mississippi State Medical Association. 18: 57-60. PMID 859174 |
0.014 |
|
| 1986 |
Douglas GR, Hugenholtz AP, Blakey DH. Genetic toxicology of phthalate esters: mutagenic and other genotoxic effects. Environmental Health Perspectives. 65: 255-62. PMID 3709450 |
0.013 |
|
| 1932 |
Blakey D. William Lane and the minerva press Notes and Queries. 162: 208. DOI: 10.1093/nq/CLXII.mar19.208 |
0.013 |
|
| 1976 |
Filion WG, MacPherson P, Blakey D, Yen S, Culpeper A. Enhanced Hoechst 33258 fluorescence in plants Experimental Cell Research. 99: 204-206. DOI: 10.1016/0014-4827(76)90701-1 |
0.013 |
|
| 1982 |
Blakey DH, Vosa CG. Heterochromatin and chromosome variation in cultivated species of Tulipa subg. Leiostemones (Liliaceae) Plant Systematics and Evolution. 139: 163-178. DOI: 10.1007/BF00989323 |
0.013 |
|
| 1981 |
Blakey DH, Vosa CG. Heterochromatin and chromosome variation in cultivated species of Tulipa subg. Eriostemones (Liliaceae) Plant Systematics and Evolution. 139: 47-55. DOI: 10.1007/BF00983921 |
0.013 |
|
| 1982 |
Carl M, Blakey DL, Francis DP, Maynard JE. Interruption of hepatitis B transmission by modification of a gynaecologist's surgical technique. Lancet. 1: 731-3. PMID 6122020 DOI: 10.1016/S0140-6736(82)92636-8 |
0.011 |
|
| 1959 |
BLAKEY D. Poliomyelitis in Mississippi: preliminary report, 1958. The Mississippi Doctor. 37: 43-5. PMID 13666666 |
0.01 |
|
| 2013 |
Blakey DC. Factors impacting the tumor localization and distribution of antibody-based therapeutics in oncology Development of Antibody-Based Therapeutics: Translational Considerations. 241-253. DOI: 10.1007/978-1-4419-5955-3_9 |
0.01 |
|
| 2010 |
Zafar NB, Stephens D, Larsson M, Sakaguchi R, Clive M, Sampath R, Museth K, Blakey D, Gazdik B, Thomas R. Destroying la for "2012" Acm Siggraph 2010 Talks, Siggraph '10. a25. DOI: 10.1145/1837026.1837059 |
0.01 |
|
| 2008 |
Blakey D, Galloway SM, Kirkland DJ, MacGregor JT. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment. Mutation Research. 657: 84-90. PMID 18926925 DOI: 10.1016/j.mrgentox.2008.09.004 |
0.01 |
|
| 2005 |
Robinson SP, Kalber TL, Howe FA, McIntyre DJ, Griffiths JR, Blakey DC, Whittaker L, Ryan AJ, Waterton JC. Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging. Neoplasia (New York, N.Y.). 7: 466-74. PMID 15967099 DOI: 10.1593/neo.04622 |
0.01 |
|
| 2003 |
Robinson SP, McIntyre DJ, Checkley D, Tessier JJ, Howe FA, Griffiths JR, Ashton SE, Ryan AJ, Blakey DC, Waterton JC. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. British Journal of Cancer. 88: 1592-7. PMID 12771928 DOI: 10.1038/sj.bjc.6600926 |
0.01 |
|
| 1995 |
Blakey DC. Does forensic science give value for money? Science and Justice. 35: 1-4. DOI: 10.1016/S1355-0306(95)72620-X |
0.01 |
|
| 1993 |
Mayhew JF, Blakey DN. Epidural anesthesia and peroneal nerve injury. Anesthesia and Analgesia. 77: 868-9. PMID 8280280 |
0.01 |
|
| 1988 |
Blakey DC, Thorpe PE. Treatment of malignant disease and rheumatoid arthritis using ricin A-chain immunotoxins. Scandinavian Journal of Rheumatology. Supplement. 76: 279-87. PMID 2472000 DOI: 10.3109/03009748809102979 |
0.01 |
|
| 1982 |
Powell KE, Blakey DL. Concurrent evaluation of epidemic St. Louis encephalitis: are you on the upward or downward side of the curve? American Journal of Public Health. 72: 62-4. PMID 7053624 |
0.01 |
|
| 1981 |
Reves R, Blakey D, Snider DE, Farer LS. Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. American Journal of Epidemiology. 113: 423-35. PMID 6782863 |
0.01 |
|
| 1978 |
Powell KE, Taylor A, Phillips BJ, Blakey DL, Campbell GD, Kaufman L, Kaplan W. Cutaneous Sporotrichosis in Forestry Workers: Epidemic Due to Contaminated Sphagnum Moss Jama: the Journal of the American Medical Association. 240: 232-235. DOI: 10.1001/jama.1978.03290030050018 |
0.01 |
|
| 1977 |
Powell KE, Blakey DL. St Louis encephalitis. The 1975 epidemic in Mississippi. Jama. 237: 2294-8. PMID 576922 DOI: 10.1001/jama.1977.03270480034015 |
0.01 |
|
| 1976 |
Powell KE, Blakey DL. St. Louis encephalitis: clinical and epidemiologic aspects, Mississippi, 1974. Southern Medical Journal. 69: 1121-5. PMID 968523 DOI: 10.1001/jama.1975.03250120011008 |
0.01 |
|
| 1975 |
Powell KE, Blakey DL. Letter: St. Louis encephalitis. Jama. 232: 1219. PMID 1173381 DOI: 10.1001/jama.232.12.1219 |
0.01 |
|
| 1975 |
Blakey D. Editorial: Smoking mothers and infant health. Journal of the Mississippi State Medical Association. 16: 14. PMID 1113294 |
0.01 |
|
| 1975 |
Blakey D. Letter: Diiodohydroxyquin warning. Journal of the Mississippi State Medical Association. 16: 46. PMID 122845 |
0.01 |
|
| 1966 |
Blakey DH, Dewhurst CJ, Tipton RH. The long term results after marsupialization of Bartholin's cysts and abscesses. The Journal of Obstetrics and Gynaecology of the British Commonwealth. 73: 1008-9. PMID 5954184 |
0.01 |
|
| 1960 |
BLAKEY DL. Immunological aspects of tuberculosis control. Journal of the Mississippi State Medical Association. 1: 499-503. PMID 13801269 |
0.01 |
|
| 1960 |
BLAKEY DL, HOFSTRA R, GILBERTSON E, WYMAN JG. Experiment in enthusiasm. Public Health Reports. 75: 507-12. PMID 13801268 |
0.01 |
|
| 1959 |
Blakey DH. DEFIBRINATION SYNDROME IN PREGNANCY The Lancet. 273: 52-53. |
0.01 |
|
| 1959 |
Blakey DH. Vulva and vagina: The treatment of bartholin's cysts by marsupialization Obstetrical and Gynecological Survey. 14: 409-412. |
0.01 |
|
| 1958 |
BLAKEY DH. [The treatment of Bartholin's cysts by marsupialization]. The Journal of Obstetrics and Gynaecology of the British Empire. 65: 800-2. PMID 13588439 |
0.01 |
|
| 1957 |
BLAKEY DH. Puerperal surgery and umbilical hernia. Lancet. 273: 1312-4. PMID 13492634 |
0.01 |
|
| Hide low-probability matches. |